⌘K

Login Start Free

Home/Filings/4/0000899243-21-015957

4//SEC Filing

Verma Ajay 4

Accession 0000899243-21-015957

CIK 0001445283other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 4:14 PM ET

Size

5.6 KB

Accession

0000899243-21-015957

Insider Transaction Report

Form 4

Period: 2021-04-13

YUMANITY THERAPEUTICS, INC.YMTX

EVP, Head of R&D

Transactions

Award
Stock Option (Right to Buy)
2021-04-13−84,000→ 84,000 total
Exercise: $17.60Exp: 2031-04-12→ Common Stock (84,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the option shall vest on April 13, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

YUMANITY THERAPEUTICS, INC.

CIK 0001445283

Entity typeother

Related Parties

1

filerCIK 0001828155

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 4:14 PM ET
Size: 5.6 KB

View on SEC.gov